Form D · Pharmaceuticals
Avid SPV, LLC
Tustin, CA · CIK 0001853441
Offering snapshot reported Mar 25, 2021 · SEC filing
- Reported sold
- $144M Offering amount: $144M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Mar 12, 2021 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 25, 2021 | Initial | $143,750,000 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Debt, Option to acquire, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-393544
Exchangeable Notes
Source: Form D, filed Mar 25, 2021. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Joseph Carleone | Director |
| Nicholas Green | Executive |
| Daniel Hart | Director, Executive |
| Gregory Sargen | Director |
| Mark Ziebell | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
2642 Michelle Drive Suite 200
Tustin, CA, 92780
Tustin, CA, 92780